scholarly article | Q13442814 |
P50 | author | Matthew A. Mulvey | Q55979450 |
P2093 | author name string | Bijaya K Dhakal | |
P2860 | cites work | Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte function in vitro | Q24627507 |
RTX proteins: a highly diverse family secreted by a common mechanism | Q24630254 | ||
Paxillin comes of age | Q24657852 | ||
Histone modifications induced by a family of bacterial toxins | Q24679868 | ||
Global functional analyses of cellular responses to pore-forming toxins | Q27312103 | ||
Enterokinase (enteropeptidase): comparative aspects | Q28269996 | ||
Virulence factors in Escherichia coli urinary tract infection | Q28468751 | ||
Modulation of NF-κB signalling by microbial pathogens | Q28709497 | ||
Contribution of Escherichia coli alpha-hemolysin to bacterial virulence and to intraperitoneal alterations in peritonitis | Q30304556 | ||
Alpha-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis | Q30486501 | ||
Listeria monocytogenes transiently alters mitochondrial dynamics during infection | Q30498309 | ||
Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder | Q30540440 | ||
Keratinocytes synthesize enteropeptidase and multiple forms of trypsinogen during terminal differentiation | Q30893901 | ||
Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation | Q30903480 | ||
In situ activation of caspases and serine proteases during apoptosis detected by affinity labeling their enzyme active centers with fluorochrome-tagged inhibitors | Q33184357 | ||
Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli | Q33290835 | ||
Activation of the unfolded protein response is required for defenses against bacterial pore-forming toxin in vivo. | Q33375026 | ||
Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli | Q33519502 | ||
Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism | Q33592569 | ||
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics | Q33826366 | ||
Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli | Q33883358 | ||
Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. | Q34008358 | ||
Caspases - an update | Q34012617 | ||
Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic Escherichia coli with terminally differentiated human urothelial cells. | Q34300908 | ||
RAB-5- and RAB-11-dependent vesicle-trafficking pathways are required for plasma membrane repair after attack by bacterial pore-forming toxin. | Q34673172 | ||
Attenuation of human neutrophil migration and function by uropathogenic bacteria. | Q34975465 | ||
Covert operations of uropathogenic Escherichia coli within the urinary tract | Q35966152 | ||
Human mesotrypsin defies natural trypsin inhibitors: from passive resistance to active destruction | Q36200333 | ||
Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes? | Q36258460 | ||
Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli | Q36313895 | ||
Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte viability in vitro. | Q36440663 | ||
Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins | Q36536668 | ||
Pore-forming toxins and cellular non-immune defenses (CNIDs). | Q36711858 | ||
Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. | Q36747117 | ||
The emerging role of serine proteases in apoptosis | Q36826016 | ||
Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis | Q36974898 | ||
Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains | Q36980944 | ||
Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway. | Q37029864 | ||
Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity | Q37066599 | ||
Serine peptidases: classification, structure and function | Q37079798 | ||
Bone morphogenetic protein 4 signaling regulates epithelial renewal in the urinary tract in response to uropathogenic infection | Q37227229 | ||
Role of MAPK p38 in the cellular responses to pore-forming toxins. | Q37769785 | ||
Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli | Q38293889 | ||
The repeat domain of Escherichia coli haemolysin (HlyA) is responsible for its Ca2+-dependent binding to erythrocytes | Q38346172 | ||
beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer | Q38361640 | ||
Acylation of Escherichia coli hemolysin: a unique protein lipidation mechanism underlying toxin function. | Q39523324 | ||
Pore-forming toxins induce multiple cellular responses promoting survival. | Q39553466 | ||
Association of RTX toxins with erythrocytes | Q39826559 | ||
Uropathogenic Escherichia coli dominantly suppress the innate immune response of bladder epithelial cells by a lipopolysaccharide- and Toll-like receptor 4-independent pathway | Q40016803 | ||
Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores | Q40171498 | ||
Cytocidal effects of Escherichia coli hemolysin on human T lymphocytes | Q40266825 | ||
Why Escherichia coli alpha-hemolysin induces calcium oscillations in mammalian cells--the pore is on its own. | Q40295280 | ||
Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. | Q40302030 | ||
Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium | Q40926236 | ||
Invasion of epithelial cells and proteolysis of cellular focal adhesion components by distinct types of Porphyromonas gingivalis fimbriae | Q41476453 | ||
Relevance of fatty acid covalently bound to Escherichia coli alpha-hemolysin and membrane microdomains in the oligomerization process | Q42576844 | ||
Human-Restricted Bacterial Pathogens Block Shedding of Epithelial Cells by Stimulating Integrin Activation | Q42919010 | ||
CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion | Q44220432 | ||
Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment. | Q45986472 | ||
Role of alpha-hemolysin for the in vitro phagocytosis and intracellular killing of Escherichia coli. | Q46022864 | ||
E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model | Q46417447 | ||
Aerolysin induces G-protein activation and Ca2+ release from intracellular stores in human granulocytes | Q47859943 | ||
Escherichia coli alpha-haemolysin induces focal leaks in colonic epithelium: a novel mechanism of bacterial translocation. | Q52925469 | ||
Carbon monoxide prevents apoptosis induced by uropathogenic Escherichia coli toxins. | Q54472830 | ||
Intracellular bacterial biofilm-like pods in urinary tract infections. | Q54522305 | ||
Interaction of the bacterial protein toxin alpha-haemolysin with model membranes: protein binding does not always lead to lytic activity. | Q54604025 | ||
Haemolysin contributes to virulence of extra-intestinal E. coli infections | Q59085495 | ||
Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli | Q64449884 | ||
Calcium-dependent conformation of E. coli alpha-haemolysin. Implications for the mechanism of membrane insertion and lysis | Q74158025 | ||
P433 | issue | 1 | |
P921 | main subject | proteolysis | Q33123 |
cell adhesion | Q187640 | ||
P304 | page(s) | 58-69 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | Cell Host & Microbe | Q5058153 |
P1476 | title | The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways | |
P478 | volume | 11 |
Q34298360 | A conserved PapB family member, TosR, regulates expression of the uropathogenic Escherichia coli RTX nonfimbrial adhesin TosA while conserved LuxR family members TosE and TosF suppress motility |
Q54977516 | A new role for Zinc limitation in bacterial pathogenicity: modulation of α-hemolysin from uropathogenic Escherichia coli. |
Q104471866 | Activation of NLRP3 by uropathogenic Escherichia coli is associated with IL-1β release and regulation of antimicrobial properties in human neutrophils |
Q52431620 | Activation of the NLRP3 Inflammasome Pathway by Uropathogenic Escherichia coli Is Virulence Factor-Dependent and Influences Colonization of Bladder Epithelial Cells. |
Q91260456 | Alpha-hemolysin of uropathogenic Escherichia coli induces GM-CSF-mediated acute kidney injury |
Q36634934 | Association of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract |
Q33403953 | Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets |
Q34595898 | Bacterial lysis liberates the neutrophil migration suppressor YbcL from the periplasm of uropathogenic Escherichia coli |
Q83436908 | Bacterial pathogenesis: UPEC helps host to exfoliate |
Q36281342 | Campylobacter jejuni increases flagellar expression and adhesion of noninvasive Escherichia coli: effects on enterocytic Toll-like receptor 4 and CXCL-8 expression |
Q34635273 | Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis |
Q90424929 | Complex Multilevel Control of Hemolysin Production by Uropathogenic Escherichia coli |
Q38524810 | Cutaneous Immune Defenses Against Staphylococcus aureus Infections |
Q33730087 | Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritis |
Q36506173 | Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder |
Q33601086 | DFI-seq identification of environment-specific gene expression in uropathogenic Escherichia coli |
Q58711895 | Dysregulated hemolysin liberates bacterial outer membrane vesicles for cytosolic lipopolysaccharide sensing |
Q35134655 | Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection |
Q35980554 | Establishment and Characterization of UTI and CAUTI in a Mouse Model. |
Q34595976 | FNR regulates expression of important virulence factors contributing to pathogenicity of uropathogenic Escherichia coli. |
Q54239578 | Group B streptococcus exploits vaginal epithelial exfoliation for ascending infection. |
Q34440629 | How to make it in the urinary tract: a tutorial by Escherichia coli |
Q37443061 | Human milk oligosaccharides protect bladder epithelial cells against uropathogenic Escherichia coli invasion and cytotoxicity |
Q39165446 | Immunity to uropathogens: the emerging roles of inflammasomes |
Q42040264 | Immunomodulation in the canine endometrium by uteropathogenic Escherichia coli |
Q35687994 | Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis. |
Q37593454 | Invasion of Host Cells and Tissues by Uropathogenic Bacteria. |
Q37345901 | Lipopolysaccharide Domains Modulate Urovirulence |
Q37714172 | Metabolomic analysis of siderophore cheater mutants reveals metabolic costs of expression in uropathogenic Escherichia coli |
Q36878446 | Molecular Characterization of the Vacuolating Autotransporter Toxin in Uropathogenic Escherichia coli |
Q37405517 | Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells |
Q39181244 | Neutrophils and Immunity: From Bactericidal Action to Being Conquered. |
Q28972267 | Pathogenesis of Streptococcus urinary tract infection depends on bacterial strain and β-hemolysin/cytolysin that mediates cytotoxicity, cytokine synthesis, inflammation and virulence |
Q34297628 | Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges |
Q37547007 | Purine Biosynthesis Metabolically Constrains Intracellular Survival of Uropathogenic Escherichia coli |
Q64906403 | Rapid Remodeling of the Host Epithelial Cell Proteome by the Listeriolysin O (LLO) Pore-forming Toxin. |
Q54230403 | Regulation of hemolysin in uropathogenic Escherichia coli fine-tunes killing of human macrophages. |
Q41175388 | Role for telomerase in Listeria monocytogenes infection |
Q35557736 | Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection |
Q36848321 | Role of pore-forming toxins in neonatal sepsis |
Q89629637 | Sex effects in pyelonephritis |
Q36902491 | Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies. |
Q44056776 | Structural and functional integrity of spermatozoa is compromised as a consequence of acute uropathogenic E. coli-associated epididymitis |
Q35740396 | Structure of a bacterial toxin-activating acyltransferase. |
Q26770272 | Subversion of Host Innate Immunity by Uropathogenic Escherichia coli |
Q35817426 | Switching Rho GTPase activation into effective antibacterial defenses requires the caspase-1/IL-1beta signaling axis |
Q91753541 | The Extracellular Domain of the β2 Integrin β Subunit (CD18) Is Sufficient for Escherichia coli Hemolysin and Aggregatibacter actinomycetemcomitans Leukotoxin Cytotoxic Activity |
Q38068485 | The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives. |
Q38849245 | The role of the prostate in male fertility, health and disease. |
Q38563209 | The yin-yang driving urinary tract infection and how proteomics can enhance research, diagnostics, and treatment |
Q55223164 | TosR-Mediated Regulation of Adhesins and Biofilm Formation in Uropathogenic Escherichia coli. |
Q38501348 | Urinary tract infection of mice to model human disease: Practicalities, implications and limitations. |
Q27022487 | Urinary tract infections: epidemiology, mechanisms of infection and treatment options |
Q27313968 | Uropathogenic E. coli Exploit CEA to Promote Colonization of the Urogenital Tract Mucosa |
Q40888748 | Uropathogenic Escherichia coli Epigenetically Manipulate Host Cell Death Pathways |
Q36097500 | Uropathogenic Escherichia coli Releases Extracellular Vesicles That Are Associated with RNA |
Q38327739 | Uropathogenic Escherichia coli modulates innate immunity to suppress Th1-mediated inflammatory responses during infectious epididymitis |
Q34876396 | Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection |
Q37035981 | Uropathogenic Escherichia coli-Associated Exotoxins |
Q26782598 | Virulence and Fitness Determinants of Uropathogenic Escherichia coli |
Search more.